Recently, however, there has been a growing trend of "microdosing" GLP-1s, a practice that involves using smaller-than-prescribed doses of these drugs
By activating GLP-1 receptors, semaglutide helps individuals feel fuller on smaller portions, reducing snacking between meals and dampening the constant mental pull towards food that many people experience
What is frustrating is that for many people, standard digestive advice does not fix it
16 Loomba R, Hartman ML, Lawitz EJ, et al
"We actually believe that we have an oral here that could generate the same amount of weight loss as you see with Wegovy or Ozempic, but in a pill," Jonsson added, echoing what Eli Lilly CEO Dave Ricks said during the JPMorgan Healthcare Conference earlier this month